HIV 'Pause' test: can antibodies keep virus in check without daily pills?

NCT ID NCT06908083

Summary

This study is testing if a combination of two lab-made antibodies can help the body control HIV for a longer time after people temporarily stop their regular antiretroviral therapy (ART). It involves 50 people with HIV who were in a previous study where some received these antibodies and others received a placebo. Researchers will carefully monitor when and how high the virus returns after stopping daily pills to see if the antibodies made a lasting difference.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

  • Rockefeller Institute

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.